Clinical Evaluation and Identification of Human Coronavirus Infections in Children with Acute Respiratory Infections in Xiamen, China, 2022–2024 - Scorecard - MDSpire
Advertisement
Clinical Evaluation and Identification of Human Coronavirus Infections in Children with Acute Respiratory Infections in Xiamen, China, 2022–2024
Clinical Scorecard: Clinical Evaluation and Identification of Human Coronavirus Infections in Children with Acute Respiratory Infections in Xiamen, China, 2022–2024
At a Glance
Category
Detail
Condition
Key Mechanisms
Associated with upper respiratory tract symptoms; may involve lower respiratory tract in pediatric and immunocompromised populations, leading to conditions like bronchitis and pneumonia.
Target Population
Care Setting
Key Highlights
HCoV detected in 147 cases (0.93%) among 15,281 pediatric ARTI patients.
Primary diagnoses for HCoV infections included bronchopneumonia (41.3%) and acute bronchitis (28.8%).
Wheezing was a significant clinical manifestation in HCoV-positive patients, indicating potential for severe respiratory distress.
Guideline-Based Recommendations
Diagnosis
Management
Symptomatic treatment based on clinical presentation.
Consider antiviral therapies if indicated and available.
Monitoring & Follow-up
Risks
Patient & Prescribing Data
Children hospitalized with acute respiratory tract infections.
Focus on symptomatic relief and monitoring for complications.
Clinical Best Practices
Integrate public health strategies for managing HCoV infections, such as vaccination and public awareness campaigns.
Utilize laboratory testing for accurate diagnosis of respiratory viruses.
